News

The patent, titled "Targeting KIT with Splice Switching Oligonucleotides to Induce Apoptosis of Mast Cells," covers the company’s approach of using splice-switching oligonucleotides to disrupt ...
Tricia Bonacker, a former program director at the Capital District Psychiatric Center, is fighting for her life as she waits ...
Seven months after the completion of dosing: 41% of patients (150 mg Q4W) continue to experience complete response (UAS7=0)48% of patients (150 mg Q4W) report that CSU no longer impacts their quality ...
Kate Beckinsale has sued the producers of “ Canary Black ,” alleging that she suffered a significant knee injury during ...
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology <l ...
Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...
Kate Beckinsale has filed a lawsuit against the producers of Canary Black, claiming she suffered a serious knee injury while ...
Sanofi SA (NASDAQ:SNY) on Monday agreed to acquire Blueprint Medicines Corporation (NASDAQ:BPMC). The acquisition includes a ...
The acquisition includes a rare immunology disease medicine and an advanced and early-stage immunology pipeline.
With the deal, Sanofi gains Blueprint’s portfolio of rare immunological disease treatments, including systemic mastocytosis ...